Health Protection and Promotion of Sign Language Interpreters Through Implementation of Total Worker Health®
Launched by UNIVERSITY OF ROCHESTER · Sep 21, 2023
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the well-being of sign language interpreters by testing a special health program designed just for them. The goal is to see if a program that focuses on their unique work challenges can help improve their mental and emotional health more than a general health program. Researchers believe that interpreters who take part in this new program will feel better overall compared to those who just follow standard health guidelines.
To join the study, participants need to be certified sign language interpreters who work at least 10 hours a week and are fluent in both English and American Sign Language. Participants should be between 18 and 74 years old and must be in good health. Those who are interested will take part in activities and assessments to measure their well-being throughout the trial. This study is currently looking for volunteers, so if you fit the criteria and want to help improve the well-being of sign language interpreters, this could be a great opportunity!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Bilingual in English and American Sign Language
- • Certified sign language interpreter working at least 10 hours/week in any interpreter setting.
- • Apparently healthy
- Exclusion Criteria:
- • Less than 18 year old
- • Not yet certified as a sign language interpreter
- • Unable to provide consent
About University Of Rochester
The University of Rochester is a leading academic institution dedicated to advancing medical research and improving patient care through innovative clinical trials. Renowned for its commitment to excellence in education, research, and clinical practice, the university fosters a collaborative environment that integrates cutting-edge scientific inquiry with practical applications in healthcare. With a focus on diverse therapeutic areas, the University of Rochester aims to enhance treatment options and outcomes for patients while contributing to the broader scientific community through rigorous study design and ethical standards in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rochester, New York, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported